SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-000766
Filing Date
2023-01-10
Accepted
2023-01-10 21:19:02
Documents
1
Period of Report
2023-01-06

Document Format Files

Seq Description Document Type Size
1 form4-01112023_020152.html 4  
1 form4-01112023_020152.xml 4 5221
  Complete submission text file 0001415889-23-000766.txt   6710
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TIBUTARY ST. BALTIMORE MD 21224
Business Address
JORDAN ANDREW R (Reporting) CIK: 0001206350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 23522443